V419
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for V419, covering 2015-10-30 to 2019-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) [Phase 3]